Incidence of depression ‐ short‐term: < 6 months · adults with long‐term physical conditions (18 years or older)
It is very uncertain whether pharmacological interventions changes incidence of depression ‐ short‐term: < 6 months compared with placebo (very low certainty).
1 finding from 1 review
Incidence of depression ‐ short term: < 6 months · adults with long‐term physical conditions (18 years or older)
It is very uncertain whether psychological interventions changes incidence of depression ‐ short term: < 6 months compared with treatment (very low certainty).
1 finding from 1 review
Intervention not reported
MST vs ECT ‐ symptom severity ‐ HAMD (high = poor; short term) · patients with schizophrenia
1 finding from 1 review
Intervention not reported
MST vs ECT ‐ cognitive function ‐ immediate memory (high = better; short term) · patients with schizophrenia
1 finding from 1 review
Intervention not reported
MST vs ECT ‐ cognitive function ‐ delayed memory (high = better; short term) · patients with schizophrenia
1 finding from 1 review
Intervention not reported
MST vs ECT ‐ dropout for any reason (short term) · patients with schizophrenia
It is very uncertain whether the intervention changes MST vs ECT ‐ dropout for any reason (short term) (very low certainty).
1 finding from 1 review
Intervention not reported
MST vs ECT ‐ adverse events that led to discontinuation of treatment (short term) · patients with schizophrenia
1 finding from 1 review
Health status and quality of life · bipolar disorder
1 finding from 1 review
Treatment withdrawal · bipolar disorder
1 finding from 1 review
Any reported adverse effects up to 12 weeks after starting treatment (short term) · bipolar disorder
1 finding from 1 review
Health status and quality of life · bipolar disorder
1 finding from 1 review
Treatment withdrawal · bipolar disorder
It is very uncertain whether lamotrigine changes withdrawal from treatment due to any reason, up to 12 weeks after… compared with placebo (very low certainty).
1 finding from 1 review
Any reported adverse effects up to 12 weeks after starting treatment (short term) · bipolar disorder
It is very uncertain whether lamotrigine changes any reported adverse effects up to 12 weeks after starting treatment… compared with placebo (very low certainty).
1 finding from 1 review
Intervention not reported
Depression score Scales: Beck Depression Inventory, Center for Epidemiologic Studies Short Depression Scale, Patient Health Questionnaire Direction: lower better · women aged 16 years and older who self‐report previous or current experience of intimate partner violence
1 finding from 1 review
Treatment efficacy for depression (short term: 8–9 weeks) · depression in adults with non‐communicable diseases
Behavioural activation showed no clear difference in treatment efficacy for depression (short term: 8–9 weeks) compared with any comparator (low certainty).
1 finding from 1 review
Social adjustment and functioning (medium term: 12 months) · depression in adults with non‐communicable diseases
1 finding from 1 review
Improvement in anxiety symptoms (medium term: 12 months) · depression in adults with non‐communicable diseases
1 finding from 1 review
Acceptability · depression in adults with non‐communicable diseases
Behavioural activation showed no clear difference in treatment acceptability (short term: 2 months) compared with any comparator (low certainty).
1 finding from 1 review
Improvement in depression symptoms (short term: 5–6 months) · depression in adults with non‐communicable diseases
1 finding from 1 review
Quality of life (short term: 6 months) · depression in adults with non‐communicable diseases
1 finding from 1 review